From October 1, 2023 to December 31, 2023, the company has repurchased 303,400 shares, representing 0.18% for CNY 3.9 million. With this, the company has completed the repurchase of 724,500 shares, representing 0.42% for CNY 8.97 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.06 CNY | -1.28% |
|
-3.92% | -30.95% |
1st Jan change | Capi. | |
---|---|---|
-30.95% | 24Cr | |
+12.97% | 826.94Cr | |
+3.37% | 747.39Cr | |
-15.13% | 523.48Cr | |
-9.87% | 361.56Cr | |
-19.61% | 326.07Cr | |
-12.98% | 121.63Cr | |
-30.67% | 106.27Cr | |
-10.43% | 86Cr | |
-4.54% | 86Cr |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.